Irinotecan,Leucovorin,Gemcitabine,Nab-paclitaxel
ipsen
[]
today at #gi23 data presented from the phase iii napoli 3 trial, evaluating the nalirifox regimen showed positive results in overall survival for patients with previously untreated metastatic #pancreaticcancer. learn more 
Our vision is to create a world in which all patients with pancreatic cancer will thrive. 💜